Because glioma cells express predominantly the αvand β1 subunits of integrin [29] and SDC1 can interact with bothof these submits [14], SDC1 knockdown might inhibit integrin-mediated signaling by deregulating c-src/FAK-associated signaling pathways in glioma cells. The gene discussed is PTK2; the disease is central nervous system cancer.